lorazepam has been researched along with Innate Inflammatory Response in 3 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Theodosis-Nobelos, P | 1 |
| Papagiouvannis, G | 1 |
| Kourounakis, PN | 1 |
| Rekka, EA | 1 |
| Gouse, BM | 1 |
| Spears, WE | 1 |
| Nieves Archibald, A | 1 |
| Montalvo, C | 1 |
| Müller, N | 1 |
| Schwarz, MJ | 1 |
| Dehning, S | 1 |
| Douhe, A | 1 |
| Cerovecki, A | 1 |
| Goldstein-Müller, B | 1 |
| Spellmann, I | 1 |
| Hetzel, G | 1 |
| Maino, K | 1 |
| Kleindienst, N | 1 |
| Möller, HJ | 1 |
| Arolt, V | 1 |
| Riedel, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of a Sea-safety Course on Mood, Mental Wellbeing and Inflammation[NCT04528485] | 61 participants (Actual) | Interventional | 2020-07-01 | Completed | |||
| Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial[NCT02263872] | Phase 4 | 41 participants (Actual) | Interventional | 2014-10-31 | Completed | ||
| Salicylic Augmentation in Depression[NCT03152409] | Phase 2 | 74 participants (Anticipated) | Interventional | 2018-11-15 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for lorazepam and Innate Inflammatory Response
2 other studies available for lorazepam and Innate Inflammatory Response
| Article | Year |
|---|---|
Active Anti-Inflammatory and Hypolipidemic Derivatives of Lorazepam.
Topics: Acrylates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Carrageenan; Chromans; Hu | 2019 |
Catatonia in a hospitalized patient with COVID-19 and proposed immune-mediated mechanism.
Topics: Aged; Atrial Fibrillation; Basal Ganglia; Betacoronavirus; C-Reactive Protein; Catatonia; Coronaviru | 2020 |